L'hôpital Marie-Lannelongue est un établissement de santé privé d'intérêt collectif implanté au Plessis-Robinson. Il est nommé en l'honneur de Marie Lannelongue, philanthrope française et épouse du chirurgien Odilon Lannelongue. Il est spécialisé dans la prise en charge des pathologies thoraciques.

During the past decade, Centre Chirurgical Marie Lannelongue conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Chirurgical Marie Lannelongue" #1 sponsor was "Centre Chirurgical Marie Lannelongue" with 30 trials, followed by "Nantes University Hospital" with 3 trials sponsored, "Rennes University Hospital" with 3 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored and "Groupe Hospitalier Paris Saint Joseph" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Chirurgical Marie Lannelongue" #1 collaborator was "Ministry of Health, France" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Amiens University Hospital" with 1 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator and "Biotronik France" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Centre Chirurgical Marie Lannelongue" are "Congenital Heart Disease" (6 trials), "Cardiac Surgery" (3 trials), "Acute Respiratory Distress Syndrome" (2 trials), "Antibody Mediated Rejection" (2 trials) and "Aortic Aneurysm, Thoracic" (2 trials). Many other conditions were trialed in "Centre Chirurgical Marie Lannelongue" in a lesser frequency.

Most popular intervention types in "Centre Chirurgical Marie Lannelongue" are "Other" (21 trials), "Procedure" (17 trials), "Device" (13 trials), "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "magnetic resonance imaging" (3 trials), "Angioscan" (2 trials), "Non invasive ventilation" (2 trials), "2D and 3D trans-thoracic echocardiography" (1 trials) and "4D Flow magnetic resonance imagery" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Chirurgical Marie Lannelongue" are 60 trials for "All" genders.

Currently, there are NaN active trials in "Centre Chirurgical Marie Lannelongue". 2 are not yet recruiting, 14 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Centre Chirurgical Marie Lannelongue, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Chirurgical Marie Lannelongue, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 30 trials that are defined as “Not Applicable".